Oklahoma 2026 Regular Session Status: In Committee 2 R cosponsors

SB 741 — Practice of pharmacy; allowing pharmacist to test for and initiate drug therapy for certain minor, nonchronic health conditions. Effective date.

Last action — General Order, considered and deferred

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the Senate. Introduced February 03, 2025. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the Senate.

Prognosis

Advancing 38% · moderate confidence

Where this bill stands today.

Odds of enactment

Low

How often bills like it became law.

  • In Committee

    Current position in the legislative process.

  • 2 sponsors

    2 primary, 0 co-sponsors signed on.

  • Single-party support

    Sponsorship is currently within one party (2 R).

  • Cleared a recorded vote

    Passed 1 recorded vote so far.

Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.

Bill Text

What changed in the latest version

297 added · 350 removed

Plain-language change summary

The recent changes to Senate Bill 741 allow pharmacists to conduct tests and start drug therapy for minor health issues, as long as they follow guidelines set by licensed physicians. This amendment specifies that pharmacists can use certain FDA-approved tests for decision-making. This change is significant as it empowers pharmacists to play a larger role in patient care, potentially improving access to treatment for minor health conditions without requiring a doctor's visit every time.

→
Previous
Latest
STATE OF OKLAHOMA 2 1st Session of the 60th Legislature (2025) 3 SENATE BILL 741 By:
SENATE FLOOR VERSION March 3, 2025 AS AMENDED SENATE BILL NO.
Gollihare 4 5 AS INTRODUCED 7 An Act relating to the practice of pharmacy;
741 By:
allowing pharmacist to test or screen for and initiate drug therapy for minor, nonchronic health conditions;
Gollihare 5 [ practice of pharmacy - drug therapy - tests - codification - effective date ] 8 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
specifying allowed tests;
prohibiting certain test, screening, and treatment;
amending 59 O.S.
2021, Section 353.1, as amended by Section 6, Chapter 288, O.S.L.
2022 (59 O.S.
Supp.
2024, Section 353.1), which relates to definitions used in the Oklahoma Pharmacy Act;
modifying and adding definitions;
updating statutory language and references;
providing for codification;
and providing an effective date.
BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
Req.
B.
No.
To test for minor, nonchronic health conditions under this section, the pharmacist may use any test that may guide clinical decision-making and that is:
705 Page 1 B.
To test for minor, nonchronic health conditions under this 2 section, the pharmacist may use any test that may guide clinical 3 decision-making and that is:
Approved by, cleared by, or authorized under an emergency 5 use authorization by the United States Food and Drug Administration;
Approved by, cleared by, or authorized under an emergency use authorization by the United States Food and Drug Administration;
6 and 7 2.
and SENATE FLOOR VERSION - SB741 SFLR Page 1 (Bold face denotes Committee Amendments) 2.
Waived under the federal Clinical Laboratory Improvement Amendments of 1988 (CLIA) or deemed to be CLIA-waived for use in 9 patient care settings operating under a CLIA certificate.
Waived under the federal Clinical Laboratory Improvement Amendments of 1988 (CLIA) or deemed to be CLIA-waived for use in patient care settings operating under a CLIA certificate.
Req.
4.
No.
“Assistant pharmacist” means any person presently licensed as an assistant pharmacist in the State of Oklahoma this state by the Board pursuant to Section 353.10 of this title and for the purposes of the Oklahoma Pharmacy Act shall be considered the same as a pharmacist, except where otherwise specified;
705 Page 2 4.
5.
“Assistant pharmacist” means any person presently licensed 2 as an assistant pharmacist in the State of Oklahoma this state by 3 the Board pursuant to Section 353.10 of this title and for the purposes of the Oklahoma Pharmacy Act shall be considered the same 5 as a pharmacist, except where otherwise specified;
6 5.
7 6.
SENATE FLOOR VERSION - SB741 SFLR Page 2 (Bold face denotes Committee Amendments) 6.
“Certify” or “certification of a prescription” means the review of a filled prescription by a licensed pharmacist or a 9 licensed practitioner with dispensing authority to confirm that the medication, labeling, and packaging of the filled prescription are accurate and meet all requirements prescribed by state and federal law.
“Certify” or “certification of a prescription” means the review of a filled prescription by a licensed pharmacist or a licensed practitioner with dispensing authority to confirm that the medication, labeling, and packaging of the filled prescription are accurate and meet all requirements prescribed by state and federal law.
the properties and actions of Req.
the properties and actions of drugs and dosage forms;
No.
and the etiology, characteristics, and therapeutics of the diseased state;
705 Page 3 drugs and dosage forms;
10.
and the etiology, characteristics, and 2 therapeutics of the diseased state;
3 10.
5 a.
a.
353(b)(1), or 6 b.
353(b)(1), or SENATE FLOOR VERSION - SB741 SFLR Page 3 (Bold face denotes Committee Amendments) b.
is labeled “Prescription Only”, or labeled with the 7 following statement:
is labeled “Prescription Only”, or labeled with the following statement:
Federal law restricts this drug except for to use by or on the order of a 9 licensed veterinarian.”;
Federal law restricts this drug except for to use by or on the order of a licensed veterinarian.”;
Req.
For the purposes of this paragraph, “dispenser” dispenser does not mean a person who dispenses only products to be used in animals in accordance with 21 U.S.C.
No.
Show all 113 changed rows (73 more)
Previous
Latest
705 Page 4 For the purposes of this paragraph, “dispenser” dispenser does not 2 mean a person who dispenses only products to be used in animals in 3 accordance with 21 U.S.C.
“Distribute” or “distribution” means the sale, purchase, 5 trade, delivery, handling, storage, or receipt of a product, and 6 does not include the dispensing of a product pursuant to a 7 prescription executed in accordance with 21 U.S.C.
“Distribute” or “distribution” means the sale, purchase, trade, delivery, handling, storage, or receipt of a product, and SENATE FLOOR VERSION - SB741 SFLR Page 4 (Bold face denotes Committee Amendments) does not include the dispensing of a product pursuant to a prescription executed in accordance with 21 U.S.C.
provided, 9 taking actual physical possession of a product or title shall not be required;
provided, taking actual physical possession of a product or title shall not be required;
“Drugs” means all medicinal substances and preparations recognized by the United States Pharmacopoeia Pharmacopeia and National Formulary, or any revision thereof, and all substances and preparations intended for external and/or internal use in the cure, Req.
“Drugs” means all medicinal substances and preparations recognized by the United States Pharmacopoeia Pharmacopeia and National Formulary, or any revision thereof, and all substances and preparations intended for external and/or internal use in the cure, diagnosis, mitigation, treatment, or prevention of disease in humans or animals and all substances and preparations, other than food, intended to affect the structure or any function of the body of a human or animals;
No.
SENATE FLOOR VERSION - SB741 SFLR Page 5 (Bold face denotes Committee Amendments) 18.
705 Page 5 diagnosis, mitigation, treatment, or prevention of disease in humans 2 or animals and all substances and preparations, other than food, 3 intended to affect the structure or any function of the body of a human or animals;
“Drug sample” means a unit of a prescription drug packaged under the authority and responsibility of the manufacturer that is not intended to be sold and is intended to promote the sale of the drug;
5 18.
19.
“Drug sample” means a unit of a prescription drug packaged 6 under the authority and responsibility of the manufacturer that is 7 not intended to be sold and is intended to promote the sale of the drug;
9 19.
262 for Req.
262 for such product, or if such product is not the subject of an approved application or license, the person who manufactured the product, SENATE FLOOR VERSION - SB741 SFLR Page 6 (Bold face denotes Committee Amendments) b.
No.
a co-licensed partner of the person described in subparagraph a of this paragraph that obtains the product directly from a person described in this subparagraph or subparagraph a of this paragraph, c.
705 Page 6 such product, or if such product is not the subject of 2 an approved application or license, the person who 3 manufactured the product, b.
an affiliate of a person described in subparagraph a or b of this paragraph who receives the product directly from a person described in this subparagraph or in subparagraph a or b of this paragraph, or d.
a co-licensed partner of the person described in 5 subparagraph a of this paragraph that obtains the 6 product directly from a person described in this 7 subparagraph or subparagraph a of this paragraph, c.
an affiliate of a person described in subparagraph a 9 or b of this paragraph who receives the product directly from a person described in this subparagraph or in subparagraph a or b of this paragraph, or d.
Req.
25.
No.
“Medical gas” means those gases including those in liquid state upon which the manufacturer or distributor has placed one of several cautions, such as “Rx Only”, in compliance with federal law;
705 Page 7 25.
SENATE FLOOR VERSION - SB741 SFLR Page 7 (Bold face denotes Committee Amendments) 26.
“Medical gas” means those gases including those in liquid 2 state upon which the manufacturer or distributor has placed one of 3 several cautions, such as “Rx Only”, in compliance with federal law;
“Medical gas order” means an order for medical gas issued by a licensed prescriber;
26.
27.
“Medical gas order” means an order for medical gas issued 5 by a licensed prescriber;
“Medical gas distributor” means a person licensed to distribute, transfer, wholesale, deliver, or sell medical gases on drug orders to suppliers or other entities licensed to use, administer, or distribute medical gas and may also include a patient or ultimate user;
6 27.
“Medical gas distributor” means a person licensed to 7 distribute, transfer, wholesale, deliver, or sell medical gases on drug orders to suppliers or other entities licensed to use, 9 administer, or distribute medical gas and may also include a patient or ultimate user;
lice, and Req.
lice, and e.
No.
other emerging and existing public health threats identified by the State Commissioner of Health if permitted by an order, rule, or regulation;
705 Page 8 e.
SENATE FLOOR VERSION - SB741 SFLR Page 8 (Bold face denotes Committee Amendments) 31.
other emerging and existing public health threats 2 identified by the State Commissioner of Health if 3 permitted by an order, rule, or regulation;
“Nonprescription drugs” means medicines or drugs which are sold without a prescription and which are prepackaged for use by the consumer and labeled in accordance with the requirements of the statutes and regulations of this state and the federal government.
Such items shall also include medical and dental supplies and bottled or nonbulk chemicals which are sold or offered for sale to the general public if such articles or preparations meet the requirements of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C.A., Section 321 et seq.;
“Nonprescription drugs” means medicines or drugs which are 5 sold without a prescription and which are prepackaged for use by the 6 consumer and labeled in accordance with the requirements of the 7 statutes and regulations of this state and the federal government.
Such items shall also include medical and dental supplies and 9 bottled or nonbulk chemicals which are sold or offered for sale to the general public if such articles or preparations meet the requirements of the Federal Food, Drug, and Cosmetic Act, 21 U.S.C.A., Section 321 et seq.;
31.
For the purposes of this paragraph, “individual saleable unit” means the smallest container of a product introduced Req.
For the purposes of this paragraph, “individual saleable unit” means the smallest container of a product introduced into commerce by the manufacturer or repackager that is intended by the manufacturer or repackager for individual sale to a dispenser;
No.
SENATE FLOOR VERSION - SB741 SFLR Page 9 (Bold face denotes Committee Amendments) 33.
705 Page 9 into commerce by the manufacturer or repackager that is intended by 2 the manufacturer or repackager for individual sale to a dispenser;
3 33.
“Person” means an individual, partnership, limited liability company, corporation, or association, unless the context 5 otherwise requires;
“Person” means an individual, partnership, limited liability company, corporation, or association, unless the context otherwise requires;
6 34.
34.
“Pharmacist-in-charge” or “PIC” means the pharmacist 7 licensed in this state responsible for the management control of a pharmacy and all other aspects of the practice of pharmacy in a 9 licensed pharmacy as defined by Section 353.18 of this title;
“Pharmacist-in-charge” or “PIC” means the pharmacist licensed in this state responsible for the management control of a pharmacy and all other aspects of the practice of pharmacy in a licensed pharmacy as defined by Section 353.18 of this title;
Req.
38.
No.
705 Page 10 38.
2 a.
SENATE FLOOR VERSION - SB741 SFLR Page 10 (Bold face denotes Committee Amendments) a.
the interpretation and evaluation of prescription 3 orders, b.
the interpretation and evaluation of prescription orders, b.
the compounding, dispensing, administering, and 5 labeling of drugs and devices, except labeling by a 6 manufacturer, repackager, or distributor of 7 nonprescription drugs and commercially packaged legend drugs and devices, 9 c.
the compounding, dispensing, administering, and labeling of drugs and devices, except labeling by a manufacturer, repackager, or distributor of nonprescription drugs and commercially packaged legend drugs and devices, c.
the ordering, performing, and interpreting of tests for minor, nonchronic health conditions that meet the requirements of Section 1 of this act and the initiation of drug therapy for minor, nonchronic health conditions, or Req.
the ordering, performing, and interpreting of tests for minor, nonchronic health conditions that meet the requirements of Section 1 of this act and the initiation of drug therapy for minor, nonchronic health conditions, or SENATE FLOOR VERSION - SB741 SFLR Page 11 (Bold face denotes Committee Amendments) h.
No.
the provision of those acts or services that are necessary to provide pharmaceutical care;
705 Page 11 h.
39.
the provision of those acts or services that are 2 necessary to provide pharmaceutical care;
3 39.
“Preparation” means an article which may or may not contain sterile products compounded in a licensed pharmacy pursuant 5 to the order of a licensed prescriber;
“Preparation” means an article which may or may not contain sterile products compounded in a licensed pharmacy pursuant to the order of a licensed prescriber;
6 40.
40.
“Prescriber” means a person licensed in this state who 7 is authorized to prescribe dangerous drugs within the scope of practice of the person’s profession;
“Prescriber” means a person licensed in this state who is authorized to prescribe dangerous drugs within the scope of practice of the person’s profession;
9 41.
41.
Req.
SENATE FLOOR VERSION - SB741 SFLR Page 12 (Bold face denotes Committee Amendments) 43.
No.
705 Page 12 43.
“Repackager”, including “virtual repackager”, means a 2 person who owns or operates an establishment that repacks and 3 relabels a product or package for further sale or distribution without further transaction;
“Repackager”, including “virtual repackager”, means a person who owns or operates an establishment that repacks and relabels a product or package for further sale or distribution without further transaction;
5 44.
44.
“Sterile drug” means a drug that is intended for 6 parenteral administration, an ophthalmic or oral inhalation drug in 7 aqueous format, or a drug that is required to be sterile under state and federal law;
“Sterile drug” means a drug that is intended for parenteral administration, an ophthalmic or oral inhalation drug in aqueous format, or a drug that is required to be sterile under state and federal law;
9 45.
45.
“Supportive personnel” means technicians and auxiliary supportive persons who are regularly paid employees of a pharmacy Req.
“Supportive personnel” means technicians and auxiliary supportive persons who are regularly paid employees of a pharmacy SENATE FLOOR VERSION - SB741 SFLR Page 13 (Bold face denotes Committee Amendments) who work and perform tasks in the pharmacy as authorized by Section 353.18A of this title;
No.
47.
705 Page 13 who work and perform tasks in the pharmacy as authorized by Section 2 353.18A of this title;
3 47.
“Third-party logistics provider” including “virtual third-party logistics provider” means an entity that provides or 5 coordinates warehousing, or other logistics services of a product in 6 interstate commerce on behalf of a manufacturer, wholesale 7 distributor, or dispenser of a product but does not take ownership of the product, nor have responsibility to direct the sale or 9 disposition of the product.
“Third-party logistics provider” including “virtual third-party logistics provider” means an entity that provides or coordinates warehousing, or other logistics services of a product in interstate commerce on behalf of a manufacturer, wholesale distributor, or dispenser of a product but does not take ownership of the product, nor have responsibility to direct the sale or disposition of the product.
Req.
SENATE FLOOR VERSION - SB741 SFLR Page 14 (Bold face denotes Committee Amendments) 51.
No.
705 Page 14 51.
“Unit dose package” means a package that contains a 2 single dose drug with the name, strength, control number, and 3 expiration date of that drug on the label;
“Unit dose package” means a package that contains a single dose drug with the name, strength, control number, and expiration date of that drug on the label;
“Unit of issue package” means a package that provides 5 multiple doses of the same drug, but each drug is individually 6 separated and includes the name, lot number, and expiration date.
“Unit of issue package” means a package that provides multiple doses of the same drug, but each drug is individually separated and includes the name, lot number, and expiration date.
7 SECTION 3.
SECTION 3.
8 60-1-705 DC 1/19/2025 5:42:21 AM Req.
COMMITTEE REPORT BY:
No.
COMMITTEE ON HEALTH AND HUMAN SERVICES March 3, 2025 - DO PASS AS AMENDED SENATE FLOOR VERSION - SB741 SFLR Page 15 (Bold face denotes Committee Amendments)
705 Page 15
⬇ Download PDF
View plain text versions (2)

How this bill changes current law

4 changes Share ↗

AI-generated reading aid from the bill's amendatory text — verify against the official bill.

The bill establishes a framework for pharmacists in Oklahoma to test and initiate drug therapy for certain minor health conditions under specific regulations.

  • A. In accordance with a standing order issued by a licensed allopathic or osteopathic physician or by the medical director of a county or local health department, a pharmacist may test or screen for and initiate drug therapy for minor, nonchronic health conditions as defined in Section 353.1 of Title 59 of the Oklahoma Statutes.

    This addition allows pharmacists to test and initiate drug therapy for specified health conditions.

  • B. To test for minor, nonchronic health conditions under this section, the pharmacist may use any test that may guide clinical decision-making and that is: 1. Approved by, cleared by, or authorized under an emergency use authorization by the United States Food and Drug Administration; and 2. Waived under the federal Clinical Laboratory Improvement Amendments of 1988 (CLIA) or deemed to be CLIA-waived for use in patient care settings operating under a CLIA certificate.

    This specifies the types of tests pharmacists can use for screening and testing minor, nonchronic health conditions.

  • C. A pharmacist shall not test or screen for streptococcus or initiate drug therapy for streptococcus to individuals under six (6) years of age.

    This establishes a restriction on pharmacists conducting certain tests for young children.

  • 59 O.S. 2021, Section 353.1

    30. “Minor, nonchronic health condition” means a typically short-term health condition that is generally managed with noncontrolled drug therapies, minimal treatment, or self-care, and is limited to the following: a. influenzas, b. streptococcus, c. SARS-CoV-2, d. lice, and e. other emerging and existing public health threats identified by the State Commissioner of Health if permitted by an order, rule, or regulation; → 30. “Minor, nonchronic health condition” means a typically short-term health condition that is generally managed with noncontrolled drug therapies, minimal treatment, or self-care.

    The definition is streamlined by removing specific examples of conditions.

Action History

  1. General Order, considered and deferred

  2. Coauthored by Representative Roe (principal House author)

  3. Placed on General Order

  4. Title stricken

  5. Reported Do Pass as amended Health and Human Services committee; CR filed

  6. Second Reading referred to Health and Human Services

  7. Authored by Senator Gollihare

  8. First Reading

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

2 sponsors · 0 co-sponsors · 149 not signed on · 1 voted No

Sponsors (2)

Co-sponsors (0)

None.

Not signed on (149)

149 members have not signed on to this bill.

Show all 149 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Health & Human Services

Passed 10 Yea · 1 Nay
Party YeaNayPresentNot Voting
Republican 7100
Democrat 3000
Unaffiliated 0001
Total 10101
% of votes cast 83%8%0%8%
How each member voted (12)
Member Party Vote
STRIKE THE TITLE - ADOPTED — Not Voting
Carri Hicks Democrat Yea
Jo Anna Dossett Democrat Yea
Nikki Nice Democrat Yea
Aaron Reinhardt Republican Yea
Bill Coleman Republican Yea
Brenda Stanley Republican Yea
John Haste Republican Yea
Julie McIntosh Republican Nay
Kristen Thompson Republican Yea
Lisa Standridge Republican Yea
Paul Rosino Republican Yea

Official roll call →

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

Who sponsors SB 741?
SB 741 is sponsored by Todd Gollihare (Republican) and Cynthia Roe (Republican).
What is the current status of SB 741?
This bill is in committee in the Senate. Introduced February 03, 2025. It must pass committee before a floor vote.
Where can I track SB 741?
Track SB 741 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 741

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 741

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →